Corrigendum to “Gold core@CeO2 halfshell Janus nanocomposites catalyze targeted sulfate radical for periodontitis therapy” [Journal of Controlled Release 370 (2024) 600–613]

IF 10.5 1区医学 Q1 CHEMISTRY, MULTIDISCIPLINARY

Journal of Controlled Release Pub Date : 2024-11-26 DOI:10.1016/j.jconrel.2024.11.049

Sijia Li , Qihang Ding , Lingling Zhang , Fangyu Shi , Chengyu Liu , Tingxuan Li , Yujia Shi , Manlin Qi , Lin Wang , Biao Dong , Shuyan Song , Jiao Sun , Jong Seung Kim , Chunyan Li

引用次数: 0

查看原文本刊更多论文

金核@CeO2半壳Janus纳米复合材料催化靶向硫酸根治疗牙周炎》[《控释杂志》370 (2024) 600-613] 更正

作者对发表的手稿中图 4G 中 G2 组扫描电镜图像的错误位置表示遗憾。以下是更正后的图 4，图 4G 中 G2 组的图像被替换。此更正不影响任何其他结果和科学结论：下载高清图片 (507KB)Download：下载全尺寸图片

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Journal of Controlled Release 医学-化学综合

CiteScore

18.50

自引率

5.60%

发文量

700

审稿时长

39 days

期刊介绍： The Journal of Controlled Release (JCR) proudly serves as the Official Journal of the Controlled Release Society and the Japan Society of Drug Delivery System. Dedicated to the broad field of delivery science and technology, JCR publishes high-quality research articles covering drug delivery systems and all facets of formulations. This includes the physicochemical and biological properties of drugs, design and characterization of dosage forms, release mechanisms, in vivo testing, and formulation research and development across pharmaceutical, diagnostic, agricultural, environmental, cosmetic, and food industries. Priority is given to manuscripts that contribute to the fundamental understanding of principles or demonstrate the advantages of novel technologies in terms of safety and efficacy over current clinical standards. JCR strives to be a leading platform for advancements in delivery science and technology.